Group B Streptococcus Vaccine from United States
Capsular polysaccharide-CRM197 conjugate vaccine for maternal immunization against neonatal GBS disease. This vaccine is a bacterial culture-based immunological product for prophylactic use. It is classified under tariff item 3002.49.00 as an 'other' vaccine.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the vaccine is approved by Health Canada or has a clinical trial authorization
• Provide documentation on the vaccine's composition and manufacturing process
• Declare the product under tariff item 3002.49.00 and be prepared for potential inspection